Recent advances in Staphylococcus aureus infection: focus on vaccine development
Staphylococcus aureus normally colonizes the nasal cavity and pharynx. After breaching the
normal habitat, the organism is able to cause a number of infections at any site of the body …
normal habitat, the organism is able to cause a number of infections at any site of the body …
[HTML][HTML] Staphylococcus aureus vaccine strategy: promise and challenges
U Chand, P Priyambada, PK Kushawaha - Microbiological Research, 2023 - Elsevier
Staphylococcus aureus (S. aureus) is a leading and crucial infectious threat to global public
health due to the widespread emergence of antibiotic-resistant strains such as Methicillin …
health due to the widespread emergence of antibiotic-resistant strains such as Methicillin …
[HTML][HTML] Status of vaccine research and development of vaccines for Staphylococcus aureus
BK Giersing, SS Dastgheyb, K Modjarrad, V Moorthy - Vaccine, 2016 - Elsevier
Staphylococcus aureus is a highly versatile gram positive bacterium that is resident as an
asymptomatic colonizer on the skin and in the nasopharynx of approximately 30% of …
asymptomatic colonizer on the skin and in the nasopharynx of approximately 30% of …
Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies
J Clegg, E Soldaini, RM McLoughlin… - Frontiers in …, 2021 - frontiersin.org
Staphylococcus aureus is one of the most important human pathogens worldwide. Its high
antibiotic resistance profile reinforces the need for new interventions like vaccines in …
antibiotic resistance profile reinforces the need for new interventions like vaccines in …
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art
D Redi, C SPERTILLI RAFFAELLI… - NEW …, 2018 - usiena-air.unisi.it
Staphylococcus aureus is a major pathogen in both community and hospital settings. It is a
significant etiological agent to treat in healthcare-related infections due to both its ability to …
significant etiological agent to treat in healthcare-related infections due to both its ability to …
Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines
J Broughan, R Anderson, AS Anderson - Expert review of vaccines, 2011 - Taylor & Francis
Staphylococcus aureus is a common human commensal organism and also a major cause
of nosocomial infections worldwide associated with high death rates, prolonged …
of nosocomial infections worldwide associated with high death rates, prolonged …
Immunotherapeutic Approaches against Staphylococcus Aureus
NJ Verkaik, WJB Van Wamel, A Van Belkum - Immunotherapy, 2011 - Taylor & Francis
Staphylococcus aureus is a major cause of life-threatening infections such as bacteremia
and endocarditis. Unfortunately, many strains of this bacterial species have become …
and endocarditis. Unfortunately, many strains of this bacterial species have become …
[PDF][PDF] Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges
RA Proctor - Eur Cell Mater, 2015 - ecmjournal.org
Bacterial vaccines have made dramatic impacts upon morbidity and mortality caused by a
number of common pathogens, but a vaccine to prevent Staphylococcus aureus infections …
number of common pathogens, but a vaccine to prevent Staphylococcus aureus infections …
Novel targeted immunotherapy approaches for staphylococcal infection
M Otto - Expert opinion on biological therapy, 2010 - Taylor & Francis
Importance of the field: Staphylococcus aureus is a leading human pathogen in the hospital
and the community. Many S. aureus strains are resistant to antibiotics, making treatment of …
and the community. Many S. aureus strains are resistant to antibiotics, making treatment of …
Will there ever be a universal Staphylococcus aureus vaccine?
GB Pier - Human vaccines & immunotherapeutics, 2013 - Taylor & Francis
Developing a universal vaccine for S. aureus is a top priority but to date we have only had
failures in human clinical trials. Given the plethora of bacterial virulence factors, broad range …
failures in human clinical trials. Given the plethora of bacterial virulence factors, broad range …